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Over the last decade, studies on the virulence of the highly pathogenic intracellular
bacterial pathogen Francisella tularensis have increased dramatically. The organism
produces an inert LPS, a capsule, escapes the phagosome to grow in the cytosol (FPI
genes mediate phagosomal escape) of a variety of host cell types that include epithelial,
endothelial, dendritic, macrophage, and neutrophil. This review focuses on the work that
has identified and characterized individual virulence factors of this organism and we hope
to highlight how these factors collectively function to produce the pathogenic strategy
of this pathogen. In addition, several recent studies have been published characterizing
F. tularensis mutants that induce host immune responses not observed in wild type F.
tularensis strains that can induce protection against challenge with virulent F. tularensis.
As more detailed studies with attenuated strains are performed, it will be possible to see
how host models develop acquired immunity to Francisella. Collectively, detailed insights
into the mechanisms of virulence of this pathogen are emerging that will allow the design
of anti-infective strategies.
Keywords: Francisella tularensis, FPI virulence genes, phagosome escape, unique LPS, stealth strategy, capsule
mutant, virulent Schu S4
INTRODUCTION
Bacterial pathogens adopt a variety of different strategies to
infect and grow within a chosen host. In general, opportunistic
pathogens take advantage of a compromised host environment to
employ their virulence factors to generate a productive infection.
Overt pathogens, such as Francisella tularensis, have developed
sophisticated strategies to alter and/or avoid recognition and
antimicrobial killing mechanisms to reach or create a privileged
growth site within a “normal” or healthy host, causing the disease
tularemia. This organism causes disease by diverse routes, includ-
ing oral, subcutaneous, and pneumonic; the respiratory route is
of particular concern because infection with 50 or less organ-
isms is associated with mortality rates of 30–60%, if untreated
(Tarnvik and Berglund, 2003; McLendon et al., 2006). Regardless
of the route of infection, the virulence strategy of F. tularensis
involves entering host cells, escaping from the phagosome and
growing within the cytosol of the infected host. Surprisingly, the
host immune responses to these activities are delayed and signif-
icantly less than expected (Jones et al., 2012). Cells infected with
F. tularensis quickly disseminate throughout the host to the liver
and spleen. Uncontrolled growth in systemic organs causes host
cell damage, hypersecretion of cytokines and death by “cytokine
storm” (Sharma et al., 2011). Due to the extreme virulence and
ease of aerosol dissemination of F. tularensis, the US Centers for
Disease Control and Prevention have classified this organism as
a Tier 1 select agent because of its potential development into a
bioweapon (Dennis et al., 2001).
Here we review the literature describing the work that is char-
acterizing the intracellular strategy of this organism as well as
the interactions that occur between these organisms and a wide
variety of different host cell types (Conlan and North, 1992;
Forestal et al., 2003; Lindemann et al., 2007; Schulert et al., 2009;
Horzempa et al., 2010). We will highlight studies that have used
virulent F. tularensis strains since it is becoming clear that work
with model organisms (i.e., F. tularensis subsp. holarctica LVS and
F. novicida) have sometimes provided results that are different
than those obtained with the virulent strains, perhaps not sur-
prisingly since LVS is an attenuated vaccine strain. In addition,
we discuss recent work in which mutagenesis studies have identi-
fied mutants with significantly altered virulence phenotypes that
are yielding important insights into the immune evasion mecha-
nisms of virulent F. tularensis. We will discuss the virulence roles
of the unique F. tularensis LPS and capsule and we also report
the presence of glycoproteins that carry O-antigen. In addition,
we will discuss various aspects of Francisella immunology and
how attenuated F. tularensis strains are providing opportunities to
study adaptive immune in a murine model of infection. Finally,
we will attempt to provide insights into how this accumulat-
ing body of work may direct efforts to develop strains that can
provide protective immunity against F. tularensis infection.
GENETIC APPROACHES TO DISCOVER Fcrancisella
tularensis VIRULENCE MECHANISMS
Efforts to understand the molecular details of the F. tularen-
sis virulence strategy have progressed rapidly in the last decade.
These research efforts have relied on genetic approaches to iden-
tify Francisella genes that are required for various aspects of
pathogenesis. Qin and Mann (reference) performed transposon
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mutagenesis in the Schu S4 strain and identified numerous genes
required for growth in HepG2 cells, including metabolic genes
(i.e., car and pur genes, ggt, etc.) and hypothetical genes that
have been found in screens by numerous groups, including our
own. Weiss et al. identified F. novicida genes required for systemic
mouse disease by creating a library of random transposon inser-
tions in the chromosome of F. novicida (Weiss et al., 2007). This
work identified the genes on the Francisella Pathogenicity Island
(FPI, required for phagosomal escape), LPS O-antigen biosyn-
thetic genes and 44 previously unidentified genes as important
for F. novicida virulence. Many of the genes found in these screens
are important for modifying the intracellular growth niche of the
organism, acquiring nutrients or in modifying the host immune
response to the presence of the bacteria.
Our research group has performed a similar screen to iden-
tify genes in virulent F. tularensis Schu S4 required for growth in
human macrophages (Lindemann et al., 2011). Using a transpo-
son system similar to that of Weiss et al., pools of F. tularensis
Schu S4 mutants were screened for strains that were significantly
reduced in their ability to grow within human monocyte-derived
macrophages (MDMs). That work identified F. tularensis Schu
S4 mutants that were defective in production of capsule and O-
antigen, defective in FPI gene expression, nutritional mutants, as
well as many other mutants in genes with unknown functions.
These mutants are yielding important insights into Francisella
mechanisms of virulence and are providing avenues to study host
immune responses to Francisella strains that have lost some of
their virulence properties.
FACTORS IMPORTANT IN THE UPTAKE OF Francisella
tularensis INTO PHAGOCYTIC CELLS
The virulence of Francisella is dependent upon the ability of
the organisms to enter, persist and replicate within host cells
as strains that have lost these abilities are avirulent (Brotcke
and Monack, 2008; Charity et al., 2009). While it is not known
which host cells provide growth niches that are essential to
Francisella virulence, it is known that Francisella infects multiple
cell types including phagocytes such as MDMs and polymor-
phonuclear leukocytes (PMN) as well as non-phagocytic epithe-
lial and endothelial cells (Golovliov et al., 2003; Lauriano et al.,
2004; Nano et al., 2004; McCaffrey and Allen, 2006; Qin and
Mann, 2006; Schulert and Allen, 2006; Lindemann et al., 2007;
Moreland et al., 2009). Upon contact with a phagocytic cell, F.
tularensis can interact with different receptors, depending upon
the opsonization state of the organism. In studies performed with
non-opsonized Francisella, the mannose receptor plays an impor-
tant role as non-opsonized Schu S4 had reduced uptake into
macrophages acquired from mannose receptor knockout mice
compared to macrophages from wild type mice (Geier and Celli,
2011). Consistent with this observation, blocking the mannose
receptor with antibodies or soluble mannan significantly inhibits
Francisella uptake (Balagopal et al., 2006; Schulert and Allen,
2006; Geier and Celli, 2011). However, deletion or blockade of the
mannose receptor does not completely inhibit Francisella uptake,
indicating that other receptors are involved in the uptake of the
bacteria (Geier and Celli, 2011). While the reasons for the abil-
ity of this organism to use some many different receptors for
internalization into phagocytic cells is not well understood, it
does give the organism the capability to be internalized into a
wide variety of different cell types. Entry into cells via different
receptors doubtlessly activates different signaling cascades that
elicit different cytokine responses from the host cells. Research
efforts, by different groups, are aimed at understanding how
the use of different receptors for internalization of F. tularensis
impacts the infection dynamics between the pathogen and the
host.
Studies of opsonized Francisella have demonstrated that the
type of opsonization (serum vs. antibody) can alter the recep-
tor employed for internalization of the organisms. In addition,
independent of the method of opsonization, internalization of
opsonized Francisella is significantly increased compared to non-
opsonized organisms (Ben Nasr et al., 2006; Pierini, 2006; Geier
and Celli, 2011). The targets of complement opsonization appear
to be LPS and capsule, which protect the organism from the
killing activity of complement while simultaneously stimulating
the uptake of the bacteria into host cells (Clay et al., 2008). Several
studies have implicated complement receptors in the uptake of
Francisella strains (Schulert and Allen, 2006; Clay et al., 2008;
Geier and Celli, 2011; Schwartz et al., 2012). Knockout of the CR3
receptor significantly reduces internalization of serum-opsonized
Schu S4 in macrophages (Clay et al., 2008; Geier and Celli, 2011)
whereas, serum-opsonized LVS utilizes CR4 to enter MDMs and
dendritic cells (Ben Nasr et al., 2006; Schwartz et al., 2012). Both
F. tularensis Schu S4 and LVS (serum opsonized) can use CR1
and CR3 for internalization into neutrophils (Schwartz et al.,
2012). Additionally, both strains can utilize scavenger receptor
A (SRA) for uptake into MDMs (Pierini, 2006). In contrast,
IgG antibody-opsonized organisms have been shown to interact
almost exclusively with Fc receptor (FcγR), since MDMs isolated
from FcγR knockout mice are significantly reduced in their abil-
ity to internalize antibody opsonized Schu S4 (Geier and Celli,
2011). Antibody opsonization of Schu S4 has been associated
with production of superoxide and decreased intracellular growth
compared to non-opsonized bacteria (Geier and Celli, 2011).
These data indicate that Francisella has evolved multiple mech-
anisms of internalization, which appear to be equally important,
to take advantage of different host conditions and it is likely that
the mechanism of uptake is important role in the subsequent
interactions of the organism with its host.
Little is understood of the Francisella factors that mediate
uptake into host cells. Recent data from our lab has demonstrated
that the Francisella capsule and/or LPS are important in reduc-
ing uptake by phagocytes (Lindemann et al., 2011). Mutants in
the waaY and waaL genes, which produce no capsule and lack
the O-antigen side chain, displays ∼10 fold increase in uptake
into MDMs compared to wild type Schu S4 (Lindemann et al.,
2011; Rasmussen et al., 2014). One of these mutants also displays
slightly increased uptake into epithelial cells (unpublished obser-
vation). Themechanism for this increased uptake is unknown but
it is tempting to speculate that mutations that result in disrup-
tions of capsule and LPS biosynthesis either change the charge
of the bacterial surface or uncover other surface molecules that
mediate uptake. While not much is known about the bacte-
rial factors that facilitate entry of Francisella into various host
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cells, strains that display increased uptake may be valuable in
uncovering the mechanism of entry.
THE INTRACELLULAR INTERACTIONS OF Francisella
tularensis
After entry, F. tularensis is located within a phagosome that begins
to mature into a phagolysosome. Although maturation of the
phagosome progresses significantly, Francisella has the ability to
prevent fusion of the phagosome with the lysosome (Anthony
et al., 1991; Checroun et al., 2006). During this process, the
Francisella-containing phagosome (FCP) becomes decorated with
both early and late endosomal markers: EEA-1, CD63, LAMP-1,
LAMP-2, and Rab5 (Golovliov et al., 2003; Clemens et al., 2004;
Checroun et al., 2006; Santic et al., 2006). Instead of fusing with
the lysosome, the bacteria degrade the phagosomal membrane
and egress into the host cytosol between 1 and 4 h post entry
into the cell (Clemens et al., 2004, 2009; Chong et al., 2008).
Interestingly, inhibition of phagosomal acidification delays F.
tularensis escape and replication (Chong et al., 2008). The molec-
ular mechanism that allows the bacteria to escape the phagosome
is still uncharacterized but several studies have established that
disruption of FPI genes renders the bacteria unable to escape the
phagosome (Nano et al., 2004; Barker and Klose, 2007; de Bruin
et al., 2007; Nano and Schmerk, 2007; Ludu et al., 2008; Buchan
et al., 2009). In F. tularensis type A and type B strains both copies
of the FPI must be mutated to inhibit phagosomal escape.
As Francisella reaches the cytosol the bacteria begin to replicate
quickly, with data showing that virulent Schu S4 has an intracellu-
lar doubling time of ∼1 h (Chong et al., 2008). This intracellular
growth appears to last up to 48 h in vitro. Depending upon the
host cell type, the organisms can replicate 50–1500 fold (Lai et al.,
2001; Qin and Mann, 2006; Bonquist et al., 2008; Schulert et al.,
2009; Edwards et al., 2010). Eventually host cell resources are con-
sumed and the cell dies, releasing bacteria into the extracellular
environment (Lai and Sjostedt, 2003; Lai et al., 2004; Celli and
Zahrt, 2013).
Several bacterial factors that are essential for cytosolic growth
have been identified through genetic approaches. Many of these
genes are involved in metabolic pathways such as purine biosyn-
thesis (purMCD) or uracil biosynthesis (pyrF) (Pechous et al.,
2006, 2008; Horzempa et al., 2010). Recent work using F. novicida
demonstrated that the FTN1586 open reading frame, an ortholog
of ansP, encodes an asparagine transporter that is important for
cytosolic growth (Gesbert et al., 2013). Similar roles in cytosolic
growth have been identified for other transport proteins in the
LVS strain, including, FTL1645, FTL1586, and FTL0129 (Marohn
et al., 2012). Other genes have been identified that are involved
in cytosolic replication including dipA, FTT0989, ripA, and the
γ-glutamyl transpeptidase, ggt (Brotcke et al., 2006; Fuller et al.,
2008; Alkhuder et al., 2009; Wehrly et al., 2009; Chong et al.,
2012).
Three genes, migR, trmE, and cphA have been identified from
genetic screens and shown to be involved in modulating FPI
expression and growth inside of MDMs (Buchan et al., 2009;
Charity et al., 2009; Lindemann et al., 2011). It has recently been
shown by our research group that each of these genes affects
FPI expression by indirectly altering intracellular concentrations
of the alarmone ppGpp (Faron et al., 2013). The ppGpp alar-
mone has been shown to strengthen the interaction of FevR
and RNA polymerase to induce expression of FevR-dependent
genes (Charity et al., 2009). Despite each of these mutants hav-
ing reduced ppGpp concentrations, each mutant has a unique
growth pattern in different in vitro infection models. The LVS
trmE strain did not grow inside of MDM cells, but replicated
in both A549 and HEp-2 cells while the LVS migR mutant only
replicated in HEp-2 cells. The LVS cphA strain was unable to
grow in any of the three cell types (Faron et al., 2013). These
data indicate that different host cells present different intracellular
growth challenges to Francisella; the bacteria appear to respond to
these challenges via different homeostatic feedback pathways that
contribute to the intracellular ppGpp pools.
Evidence is accumulating that significant differences exist
between virulent F. tularensis strains and LVS. For instance, muta-
tion of migR decrease F. tularensis LVS virulence for mice but
deletion ofmigR in Schu S4 has a very minor effect on mouse vir-
ulence (Buchan, 2009). It is possible that this virulence difference
is due to steady-state FPI gene expression levels between Schu S4
and LVS, as iglA-lacZ reporter activity in Schu S4 is about 3-fold
higher than that observed in the LVS strain (Faron et al., 2013).
We have recently identified another difference between F.
tularensis Schu S4 and F. tularensis LVS. Using recently immor-
talized human AT-II cells (ABM), we have compared the ability
of virulent Schu S4 and LVS to enter and replicate within these
cells. Interestingly, Schu S4 grows ∼100-fold better in these air-
way epithelial cells than does LVS, suggesting that LVS attenuation
may be partly due to an inability to effectively grow within epithe-
lial lung cells (manuscript in preparation). To our knowledge, this
is the first cell type in which such a stark difference in intracellu-
lar growth is observed between Schu S4 and LVS. These results
indicate that it may be important to identify host cells that are key
growth sites for the bacteria prior to efficient dissemination to
distal organs. This knowledge may be vital in efforts to produce
live attenuated vaccine strains.
THE ATYPICAL LIPOPOLYSACCHARIDE OF Francisella
tularensis
An important contributing factor to the high virulence of this
pathogen is that its early intracellular growth appears to be
unchecked by significant host responses (Bosio, 2011). A factor
that is important in F. tularensis immune evasion is the lipid A
component of LPS. Francisella lipid A species are unusual in that
they are asymmetrical, tetraacylated and have longer than nor-
mal fatty acids chains (16–18 carbons). This is in contrast to
the lipid A from most Gram-negative bacteria that contain six
acyl chains of 12–14 carbons in length and phosphate groups
available for interactions with TLR-4 that stimulate strong proin-
flammatory responses (Raetz, 1990; Poltorak et al., 1998; Beutler
and Poltorak, 2000). For Francisella, the non-prime phosphate on
the di-glucosamine backbone can be shielded by a galactosamine
while the phosphate on the prime side of the sugar backbone is
often missing (Vinogradov et al., 2002; Phillips et al., 2004; Gunn
and Ernst, 2007). Multiple species of lipid A with some or all of
these differences may be present in the outer membrane of a sin-
gle organism (reference). The differences in the Francisella lipid A
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make the endotoxin of F. tularensis unable to bind to LBP and
therefore unable to activate TLR-4 signaling pathways, render-
ing it inert compared to typical endotoxins (Hajjar et al., 2006;
Gunn and Ernst, 2007). Several research groups are working to
understand how acylation, length of fatty acid side chains and
shielding the phosphates of the endotoxin contribute to the lack
of bioactivity of the F. tularensis LPS (Kanistanon et al., 2012).
These studies are providing important insights into how bacteria
can modify their LPS to lessen the ability of the host to recognize
their presence and activate key host cytokine pathways.
CHARACTERISTICS OF THE Francisella tularensis CAPSULE
AND ITS ROLE IN BACTERIAL VIRULENCE
The role of the Francisella capsule in immune evasion and patho-
genesis is an active area of investigation. Early work aimed at
characterization of a crude preparation of the Francisella cap-
sule revealed that it was composed of mannose, rhamnose, and
dideoxy sugars (Hood, 1977). Sandstrom et al. created an acap-
sular Francisella strain and found that it was more sensitive
to antibody-mediated killing (Sandstrom et al., 1988), although
unfortunately this strain was not preserved for additional stud-
ies. Recent work using a monoclonal antibody directed against
purified capsular material of Francisella has helped to charac-
terize some aspects of this structure (Apicella et al., 2010). The
capsule ranges in size from 100 to 250 kDa and it is present in
all type A and B strains of F. tularensis that have been exam-
ined (Apicella et al., 2010). Immunization of mice with purified
capsular material elicited circulating anti-capsule antibodies that
protected from challenge with F. tularensis LVS but did not protect
from F. tularensis Schu S4 challenge (Apicella et al., 2010).
Most bacterial capsules are large structures formed of repeat-
ing sugar subunits that are held together by glycosidic bonds
and these structures associate with the bacterial outer mem-
brane either directly or indirectly. There are four general classes
of capsules for Gram-negative bacteria based upon biochemi-
cal, genetic, serological, and physical properties (Orskov et al.,
1977; Daly et al., 1997). Of particular interest to this discus-
sion of Francisella virulence factors are Group 4 capsules. Group
4 capsules are composed of similar (often identical) O-antigen
sugars as those found in the LPS, contain acetimido sugars in
their repeat unit structures, and are greater than 100 kDa in size
(Whitfield, 2006). The capsule of Francisella has been shown
to have a molecular weight of 100–250 kDa and contain the
core sugar tetrasaccharide repeat of <2-acetamido-2,6-dideoxy-
o-glucose (o-QuiNAc), 4,6-dideoxy-4-formamido-D-glucose (o-
Qui4NFm), and 2-acetamido-2-deoxy-o-galacturnoamide (o-
GalNAcAN), with the o-GalNAcAN unit present at twice the
concentration of the other two sugars (Apicella et al., 2010;
Wang et al., 2011). This is the exact composition of the sug-
ars present in the Francisella repeating O-antigen subunits of
the LPS (Vinogradov et al., 2002; Thomas et al., 2007). In a
report characterizing the purified Francisella capsule, it was found
that neither lipid A nor 2-keto-3-deoxyoctulsonic acid (KDO)
were attached to the purified capsular structure, providing addi-
tional support that the LPS and capsule are distinct from each
other (Apicella et al., 2010). These observations indicate that the
Francisella capsule is similar to capsules produced by some strains
of the Gram-negative bacteria Vibrio cholera, Escherichia coli, and
Salmonella enterica which produce capsules that incorporate the
LPS O-antigen (Jayaratne et al., 1993; Zhang et al., 2002; Peleg
et al., 2005; Barak et al., 2007; Chen et al., 2007). Work to identify
capsule biosynthetic genes has produced mutant strains that are
disrupted for both capsule and LPS biosynthesis, indicating that
the LPS and capsule biosynthetic pathways share many compo-
nents for their assembly (unpublished observation). Efforts are
still underway to identify the genes responsible for the unique
biosynthetic steps in each pathway, such as the anchoring mech-
anism of capsule to the outer membrane, which is apparently
distinct from the lipid A anchor of LPS (Bandara et al., 2011;
Lindemann et al., 2011; Rasmussen et al., 2014).
One research group (Zarrella et al., 2011) has published data
demonstrating that an alternate non-O-antigen capsule is present
when Francisella is grown in brain heart infusion media (BHI).
This high molecular weight alternate capsule species can be
detected by PAGE in a F. tularensis LVSwbtAmutant that is unable
to produce O-antigen. This indicates that this alternate capsule
is distinct from the O-antigen capsule our research group has
described. However, the composition of this structure was not
reported. Another group also described the existence of a high
molecular weight capsule-like material present in an F. tularen-
sis LVS wbtI mutant strain, which is unable to produce O-antigen
(Bandara et al., 2011). The authors reported that this capsule-like
material was composed of glucose, galactose andmannose sugars.
While it is not known if the structures reported by Zarella et al.
and Bandara et al. are the same, both appear to be high molecular
weight capsule-like molecules and both are present in strains with
O-antigen defects.
F. tularensis PRODUCES PROTEINS THAT ARE
GLYCOSYLATED WITH THE O-ANTIGEN
Efforts to understand the roles of bacterial glycoproteins have
gained momentum from recent data indicating that some bac-
terial glycoproteins may play roles in host-pathogen interactions
(Straskova et al., 2009; Egge-Jacobsen et al., 2011; Balonova et al.,
2012). Francisella species have recently been shown to produce
significant amounts of glycoproteins, many of which appear to
be outer membrane proteins (Balonova et al., 2010). We have
recently discovered that both virulent type A and B strains of F.
tularensis produce O-antigen glycoproteins, detectable in whole
cell lysates that bind to a monoclonal antibody specific for the
O-antigen subunit (FB11, QED Biosciences). Interestingly, the
F. tularensis LVS strain does not produce detectable quantities
of these glycosylated proteins (Figure 1A). Furthermore, when
the glycoprotein profiles of Schu S4 LPS O-antigen mutants
[FTT1236 (waaY) and FTT1238c (waaB)] were compared to the
orthologous LVS mutants (FTL0708 and FTL0706, respectively),
we found that the LVS mutants lacked detectable O-antigen
reactive protein bands that are present in the Schu S4 mutants
(Figure 1B). Early work with these mutants obscured O-antigen
protein reactivity due to proteinase K digestion during sample
preparation (Lindemann et al., 2011). More recent work with
non-proteinase K treated whole cell lysates has revealed that
these strains do produce O-antigen reactive bands which can be
detected by Western blots (Figure 1C).
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FIGURE 1 | F. tularensis strains produce O-antigen glycosylated proteins.
One ml of F. tularensis broth cultures was centrifuged at 8000 × g for 2min
before resuspending the pellet in Buffer Part A, (6mM Tris, 10mM EDTA, and
2% [wt/vol] sodium dodecyl sulfate [pH 6.8]) and heated to 65◦C to sterilize
cultures. Bacterial lysates were incubated with, or without, proteinase K
(New England Biolabs, Ipswitch, MA) at 37◦C for 24 h before lyophilizing.
Approximately 14mg of bacterial material from each sample was mixed with
NuPage (Life Technologies, Carlsbad, CA) sample reducing agent and buffer,
boiled, and loaded into a 4–12% Bis-Tris NuPage gel and electrophoresed
using NuPage MES SDS running buffer (Life Technologies, Carlsbad, CA). For
immunoblots, samples were transferred to nitrocellulose and probed with
FB11 primary antibody to detect O-antigen attached to LPS or to protein
(QED Bioscience, San Diego, CA). Bands were visualized using goat
anti-mouse IgG (H+L) conjugated to horseradish peroxidase (Jackson
ImmunoResearch, West Grove, PA) and SuperSignal West Pico
chemiluminescent substrate (Pierce Biotechnology, Rockford, IL). (A)
Western blot analysis of LPS preparations from F. tularensis LVS, virulent type
B F. tularensis subsp.holarctica strains (1547 and 1623) and virulent type A F.
tularensis subsp. tularensis strains (Schu S4, MA00, and WY96) using the
O-antigen FB11 antibody for detection of bands containing O antigen, without
or with proteinase K (pk) treatment. (B) Western blot of whole cell lysates of
F. tularensis Schu S4, F. tularensis Schu S4 waaY ::TrgTn and F. tularensis Schu
S4 waaL::TrgTn, F. holarctica LVS, F. holarctica LVS waaY ::TrgTn and F.
holarctica LVS waaL::TrgTn probed with the anti-O antigen monoclonal
antibody FB11 to detect the presence of LPS O antigen laddering in these
strains. (C) Western blot analysis of F. tularensis Schu S4, F. tularensis Schu
S4 waaY ::TrgTn and F. tularensis Schu S4 waaL::TrgTn whole cell lysates
without or with (pk) proteinase K treatmenst, using O-antigen FB11 antibody.
Another group has reported findings that are consistent with
these observations. Balonova et al. (2012) reported the presence
of a Francisella lipoprotein that is glycosylated with O-antigen
sugars and that the glycosylated lipoprotein was absent in an F.
tularensis subsp. holarctica FSC200 wbtDEF mutant (Balonova
et al., 2012). We believe that protein O-antigen glycosylation,
unique to virulent F. tularensis strains, may play a role in either
the virulence of the organism or aid in evading the host immune
response. Future work in the lab is focused on understanding
the significance of O-antigen glycosylated proteins in F. tularensis
pathogenesis.
DIFFERENCES IN ADAPTIVE IMMUNE RESPONSES TO
VIRULENT F. tularensis AND F. tularensis LVS
One of the key features of the murine pneumonic tularemia
model is the rapid time to death (∼5 days post infection),
which precludes the development of a robust adaptive immune
response. This aspect of Francisella virulence has made vaccine
development a daunting challenge, and many labs have used F.
tularensis LVS as a less virulent substitute to study aspects of B and
T cell biology in sublethal infection and immunization. Evidence
is accumulating that the host response to Francisella infection is
strain-specific and responses that occur to F. tularensis LVS or F.
novicida infection may be different than those observed for vir-
ulent F. tularensis (i.e., Schu S4) (Kurtz et al., 2013; Laws et al.,
2013). This is logical; the LVS strain was purposefully selected as
a vaccine strain based upon its attenuated virulence phenotype
(Sandstrom, 1994; Elkins et al., 2003). A vaccine against fully
virulent Francisella strains will almost certainly require stimula-
tion of cellular immunity, though the mechanisms by which these
processes can be directed against Francisella remain elusive (Ray
et al., 2009; Conlan, 2011).
Protective antibodies were an early target of research into
immunity to Francisella. In studies utilizing a Type A strain,
Foshay (1946) showed that transfer of hyperimmune serum from
horses or goats provided protection to ∼70–90% of rats infected
subcutaneously, although the written details of these experiments
are vague. More recent studies utilizing the mouse model have
found contradictory results (Foshay, 1946; Kirimanjeswara et al.,
2008). Kirimanjeswara et al. found that immune serum from LVS-
immunized mice did not provide protection against Schu S4. In
vitro, however, they observed that murine alveolar macrophages
stimulated with interferon-γ were able to kill immune serum
opsonized Schu S4 (Kirimanjeswara et al., 2008). While the lat-
ter result is intriguing, Crane et al. have shown that Schu S4 may
be able to avoid this fate in vivo by interacting with the host ser-
ine protease plasmin. Schu S4 can bind to active plasmin, which
can degrade Francisella-specific antibodies (Crane et al., 2009).
The authors found that while antibody opsonization of both Schu
S4 and LVS resulted in an increase in TNF-α, the presence of
active plasmin on Schu S4, but not LVS, inhibited the induction
of TNF-α in infected cells (Crane et al., 2009). These results
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highlight a difference between the two strains that may have
important implications for how virulent Francisella species avoid
early detection and control. To that end, plasminogen knockout
mice might be an interesting model to examine the role of anti-
body opsonization and plasmin during Schu S4 infection in vivo
(Berri et al., 2013).
As with antibodies, the role of B cell activity in providing
immunity to Francisella species is complex; however, it is clear
that mice lacking B cells are less able to control or survive a
Francisella infection (Crane et al., 2012). Data is emerging that
a specific subset of B cells (B1a) can have almost opposite effects
in the host response, depending on the infecting strain and the
model of infection (Cole et al., 2009; Crane et al., 2013). Cole et al.
demonstrated that immunization with lipopolysaccharide from
LVS generated a B1a cell-dependent protective response against
an intraperitoneal challenge with ∼ 103 CFU of LVS (Cole et al.,
2009). In contrast, Crane et al. utilized a short-term low dose
antibiotic treatment after intranasal infection with Schu S4 (the
convalescent model) and observed that mice largely deficient in
B1a cells (XID mice) survived better than did wild type mice
(Crane et al., 2013). The increased survival in these mice was
found to be associated with a reduction in the anti-inflammatory
cytokine IL-10, which is a potent inhibitor of IL-12. The latter
cytokine stimulates interferon-γ production, and is necessary for
the survival of tularemia (Crane et al., 2012). Curiously, Metzger
et al. reported that IL-10−/− mice succumb to standard intranasal
Schu S4 infection similar to wild type mice, though it should be
noted that the time scales of infection are different between these
studies and direct comparisons may not be appropriate (Metzger
et al., 2013). The immune responses observed in the convalescent
model would not have time to develop in a standard intranasal
infection, although it would be of interest to see if IL-10−/−
mice phenocopy XID mice in the convalescent model of Schu S4
infection.
One possible target of the anti-inflammatory activity of IL-10
may be at the interface of antigen presenting cells and T lympho-
cytes. Hunt et al. identified a factor released by Francisella infected
cells that stimulated IL-10-dependent degradation of MHC class
II molecules in macrophages (Hunt et al., 2012). Importantly,
supernatants from Schu S4 infected macrophages have also been
shown to stimulate the downregulation ofMHC class IImolecules
(Wilson et al., 2009). These data suggest that antigen presentation
to CD4+ T cells may be reduced in vivo. This research group, as
well as others, has also shown that F. novicida and LVS induce
prostaglandin E2 (PGE2) production in infected macrophages
(Woolard et al., 2007; Wilson et al., 2009). PGE2 has been shown
to inhibit macrophage maturation, and might play a similar role
in downregulating pathways important for intracellular killing of
Francisella, as in Burkholderia pseudomallei infections (Zaslona
et al., 2012; Asakrah et al., 2013). Interestingly, these groups
showed that PGE2 induced by Francisella infection inhibited T
cell proliferation and interferon-γ production in vitro. It has long
been known that T cells are important for bacterial control and
immunity to Francisella; for an excellent summary of this liter-
ature, see Cowley and Elkins’ 2011 review (Cowley and Elkins,
2011; Crane et al., 2012; Eneslatt et al., 2012). Both CD4+ T cells
and CD8+ T cells were required for survival of a primary Schu
S4 infection in the convalescent model of tularemia, but only
partial protection against a secondary challenge was observed for
wild type mice (66% survival) (Crane et al., 2012). It is intrigu-
ing to speculate that the partial protection may be a function of
a less than optimal T cell response mediated by PGE2, both in
terms of antigen presentation and T cell proliferation. The use
of knockout mice lacking various aspects of PGE2 production
or signaling may be useful in testing this hypothesis. Our lab
has preliminarily identified Schu S4 mutants that provide some
protection against wild type Schu S4; it would be interesting to
compare PGE2 levels during infection with our strains to those of
other groups that have also shown protection (Conlan et al., 2010;
Rockx-Brouwer et al., 2012). Additionally, we are developing vec-
tors to express recombinant Francisella proteins fused to known
CD4+ and CD8+ epitopes from lymphocytic choriomeningitis
virus (LCMV) in an effort to quantify the magnitude of T cell
proliferation and maturation state during both the immunization
and challenge phases of protection studies.
SUMMARY
Significant advances have been made in understanding the vir-
ulence of F. tularensis over the last decade. The development of
genetic tools has been critical in creating F. tularensis mutants
that are defective in various aspects of virulence. The study of
mutants has provided insights into the pathogenic mechanisms
of Francisella and is pushing forward efforts to understand the
mechanisms that this pathogen uses to evade host detection. The
virulence strategy of F. tularensis has a two-pronged approach
(Figure 2). A primary thrust of the Francisella virulence strategy
is to reach the host cell cytosol as a privileged site for growth. The
organism possesses a phagosomal escape mechanism, encoded on
the FPI, which allows the organisms to disrupt the phagosomal
membrane and enter the cytosol for growth. The FPI genes, which
encode the capacity to lyse the phagosomal membrane, are cen-
tral to the ability of the pathogens to reach the cytosol. Several labs
are continuing work aimed at elucidating the molecular details of
both the host and bacterial components of this process.
A second component of the Francisella virulence strategy
employs the capsule and its unique LPS to avoid detection by
host innate immunity mechanisms. The capsule and LPS pro-
vide protection from the host complement system by protecting
the organism from complement opsonization and killing. Perhaps
even more importantly, the unique F. tularensis LPS provides
stealth to the overall virulence strategy as the lipid A does not
activate the TLR4 cytokine response pathway.
We have also highlighted in this review some of the differences
between laboratory strains of F. tularensis and virulent strains
of F. tularensis. F. tularensis Schu S4 and LVS display significant
differences in FPI gene expression levels with Schu S4 FPI expres-
sion being about 3-fold higher than LVS. Antibodies generated
against F. tularensis LPS and capsule provide significant protec-
tion against murine challenge with F. tularensis LVS while little
protection against Schu S4 challenge is observed. We also observe
that virulent Schu S4 produces significant amounts of proteins
glycosylated with O-antigen while LVS has almost undetectable
levels of those glycosylated proteins, although the significance of
these observations is still unknown. Finally, we have evidence
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FIGURE 2 | Comparison of the intracellular growth strategies of wild
type F. tularensis and a F. tularensis capsule/LPS mutant. Both wild
type and mutant organisms are internalized into a host cell, although the
absence of capsule and LPS allows increased internalization. Both strains
can escape from the phagosome. The wild type strain grows to high
numbers in the host cell cytosol before inducing death of the cell. At
late stages, organisms can be found in Francisella-containing vacuoles
(FCVs). In contrast, after mutant organisms escape the phagosome, they
grow for a short time in the cytosol before the cell dies preventing
additional growth of the organisms.
in our lab that LVS does not grow well in a human airway
epithelial cell while Schu S4 grows to high levels (manuscript in
preparation).
Importantly, there are many research groups actively trying to
understand how virulent F. tularensis suppresses a variety of host
immune responses including neutrophil and macrophage acti-
vation mechanisms. The molecular and cellular details of these
virulence mechanisms continue to be pursued in detail with the
goal of understanding the mechanisms which lead to the extreme
virulence of this bacterial pathogen as well as to develop methods
to create effective immune responses against Francisella infection.
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